This video is sponsored by the Duke Clinical Medical Series.
* Case Presentation
* Clinical Registries and Drug-eluting Stents: Results from the STENT Group in the U.S.
* Background (Cont)
* Actual Patient Outcomes New Devices in Coronary Intervention
* Selectivity of DES RCTs
* Mandated Angio FU & Clinical Events: DES RCTs
* Head-to-head SES & PES
* DES Registry Results
* Late Clinical FU: > 4000 Pts
The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.
The guest faculty, Charles Simonton, MD has indicated that he receives research/grant
support from Cordis, Boston Scientific, Possis Medical, Como MedSystems and The Medicines